Katherine Kim, MD

Kat is a study physician and therapist for a Phase 2 clinical trial for the treatment potential of psilocybin for major depressive disorder. She is a fourth year psychiatry resident at NYU Langone, where she will also be completing her geriatric psychiatry fellowship.